By Matthew Bultman ( May 14, 2018, 6:25 PM EDT) -- Anacor Pharmaceuticals Inc. on Monday lost its bid at the Federal Circuit to revive part of a patent covering toenail fungus treatment Kerydin, which the Patent Trial and Appeal Board invalidated after a challenge from a group started by hedge fund manager Kyle Bass....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.